Related Articles
Chidamide, a histone deacetylase inhibitor, induces growth arrest and apoptosis in multiple myeloma cells in a caspase‑dependent manner
Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer
Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells <em>in vitro</em>
Chidamide induces necroptosis via regulation of c‑FLIPL expression in Jurkat and HUT‑78 cells
Antitumor activity of Chidamide in hepatocellular carcinoma cell lines